Case Report on Pediatric TBI Treatment with Long-Acting Injectable Paliperidone

A single case report describes the treatment of a 9-year-old boy with severe traumatic brain injury (TBI) and post-traumatic confusional state (PTCS). The document details a multi-year pharmacological intervention, culminating in the use of long-acting injectable paliperidone palmitate, authored by Abdullah Al Ghailani and uploaded in April 2026. The 31.1 KB file is a clinical narrative summarizing the patient's progression, treatment trials, and outcomes over two years.

Use Cases

• Analyzing treatment efficacy for post-traumatic aggression based on the detailed narrative of medication trials and outcomes.
• Studying the application of long-acting injectable antipsychotics in pediatric cases based on the specific use of paliperidone palmitate.
• Investigating adverse effects in pediatric psychopharmacology based on reported weight gain and hyperprolactinemia.
• Examining functional recovery metrics in TBI based on the documented progression through Rancho Los Amigos Levels.

Strengths

• The report provides a detailed longitudinal narrative covering a specific patient's treatment over several years.
• It includes specific dosage information (100 mg then 150 mg monthly paliperidone, adjunct 2 mg risperidone) and outcome metrics (Rancho Los Amigos Level progression).
• The document is openly licensed under CC-BY-4.0.

Limitations

• The dataset is a single case report (n=1), limiting generalizability and statistical analysis.
• Row count and column-level documentation are absent; the data structure must be inferred from the narrative text.
• The 31.1 KB size indicates a very limited scope, containing primarily textual description rather than structured data.

Provenance

Source

figshare

Collection Method

Clinical case documentation and literature review.

Time Range

The case report covers events from 2022 onward, with a publication date in 2026.

Freshness

Last updated 2026-04-29 05:52:40